Legislation

Comment on DTI’s IP draft policy

On 26 November patent attorney and partner at Spoor Fisher, David Cochrane called the Department of Trade & Industry’s (dti’s) draft policy for Intellectual Property ‘unclear’. Speaking at a media briefing at the Free Market Foundation (FMF), he said the main problem was that the policy was not drafted with input from experts in IP law, which led to uncertainty in meaning, intention and compliance with the agreement on the international Trade-Related Aspects of Intellectual Property Rights (TRIPS) to which South Africa is a signatory.

Spotlight on the CAMs regulations rigmarole

Fix-a-form leaflet-labels allow for extensive amounts of information on CAMs packaging  Complementary and Alternative Medicines (CAMs) are gaining ground in the medical, health and wellness markets in South Africa. However, the sector is increasingly on government’s radar and manufacturers are now facing tougher regulations than ever before.

CAMs regulations and guidelines a disappointment

The Department_of_Health_published_regulations_for_Complementary_and_Alternative_Medicines

The Department of Health published regulations for Complementary and Alternative Medicines (CAMs) on 15 November, along with guidelines for these products’ registration published on 8 November.

Celebrating two decades of regulatory excellence

CTFA LOGOGlobal manufacturing industries are governed by regulations, the enforcement of which is overseen by associations, councils and governmental agencies. In South Africa, our cosmetics and pharmaceutical manufacturing industries are no different, with the majority of both markets operating within the scope of international guidelines.

Pharmaceutical companies fall short of B-BBEE

Keith BEECEO of BEE advisory firm EconoBEE, Keith Levenstein says that the pharmaceutical industry still has a large number of businesses that are not compliant – particularly many small- to medium-sized businesses, which are losing business as a result.

Would you like to receive our FREE e-newsletter?

* indicates required
Close